Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
FDA Workshop To Discuss Uniform Prescriber Education Requirements for Opioids September 14, 2021 Martha Garcia Add Your Comments Federal drug regulators are considering a mandatory education program for doctors dispensing opioids, to make all prescriptions for the powerful and addictive pain killers uniform across the country. A public workshop will be held by the U.S. Food and Drug Administration (FDA) on October 13-14, to reconsider mandatory prescriber education for opioids, according to an agency brief issued September 8. The workshop and proposed program come amid an ever-worsening opioid abuse epidemic in the United States, and is intended to outline a prescriber education program that would be establish a uniform set of guidelines for safe and appropriate use of the medications, as well as guidelines regarding misuse and abuse. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION A number of studies have indicated the opioid epidemic and increasing overdose deaths in recent decades has been largely driven by doctor overprescribing and offered kickbacks by drug companies. The number of dispensed opioid prescriptions has decreased since 2012, from 84 per 100 residents then, to 43 per 100 residents by 2020. However, despite those decreases, opioid-involved deaths have continued to climb, largely driven by overdoses, especially among those combining opioids with other drugs like cocaine, methamphetamine and benzodiazepines. An estimated 70% of all drug overdose deaths in the United States now involved opioids. Opioid deaths have also significantly been driven by overdose deaths involving illicit heroin and fentanyl. However, users of these substances are generally first exposed to opioids through use of prescription painkillers, experts say. As of 2020, prescription opioids were involved in 16,000 fatal overdoses per year. This is more than seen at the peak of opioid dispensing in 2012. Some public and private entities independently implemented prescriber education programs and interventions for safe opioid prescribing as abuse and overdoses began to increase, but there is no consistent program for all prescribers. “The opioid crisis continues to evolve and there are still relevant concerns with overprescribing, especially among vulnerable populations,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Although many public and private entities have independently implemented their own education programs and other interventions to encourage safe and effective prescribing practices for opioid analgesics, there is no consistent education that all prescribers are required to take about the safe use of opioid medicines. Therefore, these programs likely differ with regard to content, focus and duration.” Topics for discussion at the workshop will include the need for mandatory opioid prescriber education and the value of a single source for education on the appropriate use of opioids, risks, and treatment for opioid use disorder and abuse. Opioid REMS Program Under Consideration The agency indicates the public workshop is the first of series of discussions focusing on mandatory opioid prescriber education. The FDA is considering the need for mandatory opioid prescriber education through the Opioid Analgesic (OA) Risk Evaluation and Mitigation strategy (REMS). REMS is an FDA program typically reserved for monitoring medication with a high potential for serious adverse effects, or those such as opioids, carry a high risk of abuse or misuse. REMS programs usually require doctors go through an educational program before they are allowed to prescribe that particular drug. The FDA usually decides to place a drug in the REMS program when it is first approved by the FDA or new adverse side effects are reported. However, in some cases, REMS programs are required after a drug is already on the market due to post-marketing surveillance showing it to carry an unexpected risk. The two-day public workshop will be held October 13 and 14. A second public workshop is also being planned for the future. Details on how to attend or provide input to the workshop is available in the Federal Register notice. Tags: Drug Abuse, Drug Overdose, Opioids, Prescription Mistake Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More Lawsuit Stories Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit August 13, 2025 Tepezza Lawsuit Claims Thyroid Eye Disease Drug Caused Hearing Loss, Tinnitus August 13, 2025 Insulin Delivery Problems Lead to Tandem t:slim X2 Insulin Pump Recall: FDA August 13, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025) Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025) Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)
Woman Will Need Lifelong Monitoring After Depo-Provera Brain Tumor: Lawsuit (Posted: today) A Depo-Provera brain tumor lawsuit indicates an Ohio woman must undergo medical scans for the rest of her life after having a surgery to remove a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (08/01/2025)Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)
Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)
Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)